Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingel Demedts

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 11, 2021
Clinical implementation of value based healthcare: Impact on outcomes for lung cancer patientsIngel Demedts, Ulrike Himpe, Jelle Bossuyt, et al.
Lung Cancer (Amsterdam, Netherlands)|October 7, 2019
A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancerBenjamin Besse, Fabrice Barlesi, Ingel Demedts, et al.
Radiology|August 11, 2020
Diagnostic Performance of Chest CT for SARS-CoV-2 Infection in Individuals with or without COVID-19 SymptomsKristof De Smet, Dieter De Smet, Thomas Ryckaert, et al.
Cancers|April 13, 2023
NMR-Metabolomics Reveals a Metabolic Shift after Surgical Resection of Non-Small Cell Lung CancerElien Derveaux, Melvin Geubbelmans, Maarten Criel, et al.
ERJ Open Research|June 24, 2026
Absolute and relative intensity of physical activity after lung cancer surgeryEva Arents, Sarah Haesevoets, Francesca Van Hulle, et al.
Cancer Treatment and Research Communications|June 12, 2026
Real-world testing practices, treatment patterns, and outcomes of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor-mutated advanced/metastatic non-small cell lung cancer: An international studyJens Samol, Ingel Demedts, Mustafa Erman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2021
Lung Cancer in BelgiumSebahat Ocak, Kurt Tournoy, Thierry Berghmans, et al.
Genome Medicine|April 23, 2020
Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinomaLennart Raman, Malaïka Van der Linden, Kim Van der Eecken, et al.
Cancers|April 23, 2022
Application of an Ultrasensitive NGS-Based Blood Test for the Diagnosis of Early-Stage Lung Cancer: Sensitivity, a Hurdle Still Difficult to OvercomeMalaïka Van der Linden, Bram Van Gaever, Lennart Raman, et al.
Clinical Lung Cancer|April 11, 2022
A Randomized, Open-Label Phase II Study Evaluating Emibetuzumab Plus Erlotinib and Emibetuzumab Monotherapy in MET Immunohistochemistry Positive NSCLC Patients with Acquired Resistance to ErlotinibD Ross Camidge, Teresa Moran, Ingel Demedts, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Lung Cancer (Amsterdam, Netherlands)|November 11, 2021
Clinical implementation of value based healthcare: Impact on outcomes for lung cancer patientsIngel Demedts, Ulrike Himpe, Jelle Bossuyt, et al.
Lung Cancer (Amsterdam, Netherlands)|October 7, 2019
A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancerBenjamin Besse, Fabrice Barlesi, Ingel Demedts, et al.
Radiology|August 11, 2020
Diagnostic Performance of Chest CT for SARS-CoV-2 Infection in Individuals with or without COVID-19 SymptomsKristof De Smet, Dieter De Smet, Thomas Ryckaert, et al.
Cancers|April 13, 2023
NMR-Metabolomics Reveals a Metabolic Shift after Surgical Resection of Non-Small Cell Lung CancerElien Derveaux, Melvin Geubbelmans, Maarten Criel, et al.
ERJ Open Research|June 24, 2026
Absolute and relative intensity of physical activity after lung cancer surgeryEva Arents, Sarah Haesevoets, Francesca Van Hulle, et al.
Cancer Treatment and Research Communications|June 12, 2026
Real-world testing practices, treatment patterns, and outcomes of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor-mutated advanced/metastatic non-small cell lung cancer: An international studyJens Samol, Ingel Demedts, Mustafa Erman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2021
Lung Cancer in BelgiumSebahat Ocak, Kurt Tournoy, Thierry Berghmans, et al.
Genome Medicine|April 23, 2020
Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinomaLennart Raman, Malaïka Van der Linden, Kim Van der Eecken, et al.
Cancers|April 23, 2022
Application of an Ultrasensitive NGS-Based Blood Test for the Diagnosis of Early-Stage Lung Cancer: Sensitivity, a Hurdle Still Difficult to OvercomeMalaïka Van der Linden, Bram Van Gaever, Lennart Raman, et al.
Clinical Lung Cancer|April 11, 2022
A Randomized, Open-Label Phase II Study Evaluating Emibetuzumab Plus Erlotinib and Emibetuzumab Monotherapy in MET Immunohistochemistry Positive NSCLC Patients with Acquired Resistance to ErlotinibD Ross Camidge, Teresa Moran, Ingel Demedts, et al.
Pageof 3